Table 2.
Correlation of demographic features and co-morbidities with mortality at 28 days.
| Survivors (N = 1971) |
Non-Survivors (N = 37) |
p-Value | Odds Ratio |
95% CI | |
|---|---|---|---|---|---|
| AGE ≥ 69 | 1434 (73%) | 28 (76%) | 0.69 | 1.16 | 0.55–2.5 |
| GENDER (M) | 824 (42%) | 21 (57%) | 0.07 | 1.83 | 0.95–3.52 |
| NYHA > 2 | 1619 (82%) | 36 (%) | 0.014 | 7.82 | 1.07–57 |
| BIVENTRICULAR HEART FAILURE | 1453 (74%) | 27 (73%) | 0.57 | ||
| LEFT HEART FAILURE | 467 (24%) | 10 (27%) | 0.57 | ||
| RIGHT HEART FAILURE | 51 (2.6%) | 0 | 0.57 | ||
| HYPERTENSION (SBP ≥ 140 mm Hg) | 743 (38) | 13 (35%) | 0.75 | 0.89 | 0.45–1.8 |
| ACUTE MI | 140 (7.1%) | 3 (8%) | 0.74 | 1.15 | 0.35–3.8 |
| NEW DIAGNOSIS OF CHF | 132 (7%) | 4 (11%) | 0.32 | 1.66 | 0.6–4.6 |
| PVD | 99 (5%) | 2 (5%) | 0.71 | 1.1 | 0.26–4.5 |
| CEREBROVASCULAR DISEASE | 145 (7.4%) | 5 (13.5%) | 0.19 | 1.97 | 0.75–5.13 |
| COPD | 231 (12%) | 2 (5.4%) | 0.31 | 0.43 | 0.10–1.80 |
| CAD (Surrogate) | 715 (36%) | 15 (40%) | 0.59 | 1.2 | 0.61–2.3 |
| DIABETES | 458 (23%) | 8 (22%) | 1 | 0.91 | 0.41–2.0 |
| MODERATE-TO-SEVERE CKD | 455 (23%) | 19 (51%) | 0.00001 | 3.5 | 1.8–6.7 |
| CHRONIC LIVER DISEASE | 78 (4%) | 6 (16%) | 0.004 | 4.7 | 1.9–11.6 |
| ACUTE RENAL FAILURE | 5 (0.3%) | 2 (5.4) | 0.007 | 22.5 | 4.2–120 |
Abbreviations: CAD = coronary artery disease, CHF = congestive heart failure, CKD = chronic kidney disease, COPD = chronic obstructive pulmonary disease, M = male, MI = myocardial infarction, NYHA = New York Heart Association, PVD = peripheral vascular disease.